Table 4.
Illustrates the salivary Cp ferroxidase activities (U/ml) and specific activities in control and patients groups
Groups | Cp Ferroxidase activity (U/ml) | Cp Ferroxidase specific activity (U/mg) |
---|---|---|
| ||
Control | 0.212 | 0.040 |
Patients marsh IIIa | a0.0958 | a0.0159 |
Patients marsh IIIb | a0.097 | a0.0172 |
Patients marsh IIIc | a0.1667 | a0.0267 |
Patients marsh 0, I | a0.1687 | a0.0298 |
Significant difference in comparison to control at P<0.05.